CN1593634A - 一种养血清脑口腔崩解片及其制备方法 - Google Patents
一种养血清脑口腔崩解片及其制备方法 Download PDFInfo
- Publication number
- CN1593634A CN1593634A CN 200410049850 CN200410049850A CN1593634A CN 1593634 A CN1593634 A CN 1593634A CN 200410049850 CN200410049850 CN 200410049850 CN 200410049850 A CN200410049850 A CN 200410049850A CN 1593634 A CN1593634 A CN 1593634A
- Authority
- CN
- China
- Prior art keywords
- grams
- disintegrating agent
- oral cavity
- cavity disintegration
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000008280 blood Substances 0.000 title abstract description 6
- 210000004369 blood Anatomy 0.000 title abstract description 6
- 239000006191 orally-disintegrating tablet Substances 0.000 title abstract description 5
- 210000004556 brain Anatomy 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 74
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 34
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 34
- 239000011734 sodium Chemical class 0.000 claims abstract description 31
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 30
- 229910052708 sodium Chemical class 0.000 claims abstract description 30
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 12
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 12
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 12
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical class OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 12
- 210000000214 mouth Anatomy 0.000 claims description 64
- 150000001875 compounds Chemical class 0.000 claims description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 235000019414 erythritol Nutrition 0.000 claims description 36
- 239000003814 drug Substances 0.000 claims description 34
- 239000004386 Erythritol Substances 0.000 claims description 31
- 125000002057 carboxymethyl group Chemical class [H]OC(=O)C([H])([H])[*] 0.000 claims description 31
- 229940009714 erythritol Drugs 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000004615 ingredient Substances 0.000 claims description 20
- 229920002101 Chitin Polymers 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 17
- 239000000945 filler Substances 0.000 claims description 15
- 239000000314 lubricant Substances 0.000 claims description 15
- 229920002472 Starch Polymers 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 13
- 239000008107 starch Substances 0.000 claims description 13
- 235000019698 starch Nutrition 0.000 claims description 13
- 241000218176 Corydalis Species 0.000 claims description 12
- 241000217407 Margaritifera Species 0.000 claims description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 229940126678 chinese medicines Drugs 0.000 claims description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 235000010980 cellulose Nutrition 0.000 claims description 7
- 239000013081 microcrystal Substances 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- 239000003826 tablet Substances 0.000 abstract description 69
- 238000002474 experimental method Methods 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 9
- 230000000144 pharmacologic effect Effects 0.000 abstract description 6
- 230000009471 action Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000002131 composite material Substances 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 5
- 229940114124 ferulic acid Drugs 0.000 description 5
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 5
- 235000001785 ferulic acid Nutrition 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 5
- 241000282326 Felis catus Species 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 230000009102 absorption Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000001168 carotid artery common Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- -1 hydroxypropyl Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 239000009284 zhennaoning Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 210000000269 carotid artery external Anatomy 0.000 description 1
- 210000001326 carotid sinus Anatomy 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000009748 deglutition Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical compound COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940011964 pentobarbital sodium 30 mg Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100498507A CN1318020C (zh) | 2004-06-25 | 2004-06-25 | 一种养血清脑口腔崩解片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100498507A CN1318020C (zh) | 2004-06-25 | 2004-06-25 | 一种养血清脑口腔崩解片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1593634A true CN1593634A (zh) | 2005-03-16 |
CN1318020C CN1318020C (zh) | 2007-05-30 |
Family
ID=34665842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100498507A Expired - Lifetime CN1318020C (zh) | 2004-06-25 | 2004-06-25 | 一种养血清脑口腔崩解片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1318020C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1872217B (zh) * | 2005-06-03 | 2011-10-05 | 天津天士力制药股份有限公司 | 一种治疗头痛的药物及其制备方法 |
CN1954862B (zh) * | 2005-10-28 | 2012-03-28 | 天津天士力制药股份有限公司 | 一种治疗头痛的糖浆剂 |
CN102998375A (zh) * | 2011-09-13 | 2013-03-27 | 天士力制药集团股份有限公司 | 一种同时检测养血清脑颗粒中阿魏酸与芍药苷含量的方法 |
CN101194945B (zh) * | 2006-12-08 | 2013-06-05 | 天士力制药集团股份有限公司 | 一种治疗头痛的片剂及其制备方法 |
CN101194961B (zh) * | 2006-12-08 | 2013-06-05 | 天士力制药集团股份有限公司 | 一种治疗头痛的气雾剂及其制备方法 |
CN101194965B (zh) * | 2006-12-08 | 2013-06-05 | 天士力制药集团股份有限公司 | 一种治疗头痛的咀嚼片及其制备方法 |
CN101194964B (zh) * | 2006-12-08 | 2013-08-21 | 天士力制药集团股份有限公司 | 一种治疗头痛的包衣片剂及其制备方法 |
CN102133239B (zh) * | 2010-01-21 | 2014-08-13 | 天士力制药集团股份有限公司 | 一种中药浓缩丸及其制备方法 |
WO2015039619A1 (zh) * | 2013-09-22 | 2015-03-26 | 天士力制药集团股份有限公司 | 养血清脑制剂在制备治疗阿尔茨海默症的药物中的应用 |
CN105796729A (zh) * | 2016-03-29 | 2016-07-27 | 黑龙江大学 | 养血清脑软胶囊及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1047938C (zh) * | 1992-11-14 | 2000-01-05 | 中国人民解放军第二五四医院 | 一种治疗头痛的中药 |
TW580397B (en) * | 1997-05-27 | 2004-03-21 | Takeda Chemical Industries Ltd | Solid preparation |
CN1500513A (zh) * | 2002-11-15 | 2004-06-02 | 梅宗汉 | 治疗头痛的中药冲剂 |
-
2004
- 2004-06-25 CN CNB2004100498507A patent/CN1318020C/zh not_active Expired - Lifetime
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1872217B (zh) * | 2005-06-03 | 2011-10-05 | 天津天士力制药股份有限公司 | 一种治疗头痛的药物及其制备方法 |
CN1954862B (zh) * | 2005-10-28 | 2012-03-28 | 天津天士力制药股份有限公司 | 一种治疗头痛的糖浆剂 |
CN101194945B (zh) * | 2006-12-08 | 2013-06-05 | 天士力制药集团股份有限公司 | 一种治疗头痛的片剂及其制备方法 |
CN101194961B (zh) * | 2006-12-08 | 2013-06-05 | 天士力制药集团股份有限公司 | 一种治疗头痛的气雾剂及其制备方法 |
CN101194965B (zh) * | 2006-12-08 | 2013-06-05 | 天士力制药集团股份有限公司 | 一种治疗头痛的咀嚼片及其制备方法 |
CN101194964B (zh) * | 2006-12-08 | 2013-08-21 | 天士力制药集团股份有限公司 | 一种治疗头痛的包衣片剂及其制备方法 |
CN102133239B (zh) * | 2010-01-21 | 2014-08-13 | 天士力制药集团股份有限公司 | 一种中药浓缩丸及其制备方法 |
CN102998375A (zh) * | 2011-09-13 | 2013-03-27 | 天士力制药集团股份有限公司 | 一种同时检测养血清脑颗粒中阿魏酸与芍药苷含量的方法 |
CN102998375B (zh) * | 2011-09-13 | 2016-04-20 | 天士力制药集团股份有限公司 | 一种同时检测养血清脑颗粒中阿魏酸与芍药苷含量的方法 |
WO2015039619A1 (zh) * | 2013-09-22 | 2015-03-26 | 天士力制药集团股份有限公司 | 养血清脑制剂在制备治疗阿尔茨海默症的药物中的应用 |
CN105796729A (zh) * | 2016-03-29 | 2016-07-27 | 黑龙江大学 | 养血清脑软胶囊及其制备方法 |
CN105796729B (zh) * | 2016-03-29 | 2020-07-14 | 黑龙江大学 | 养血清脑软胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1318020C (zh) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1593634A (zh) | 一种养血清脑口腔崩解片及其制备方法 | |
CN1460517A (zh) | 复方丹参口腔崩解片及制备方法 | |
CN101032503A (zh) | 治疗心血管疾病的中药有效成分组合物及质量控制方法 | |
CN1186051C (zh) | 一种化痰止咳的药物及其生产方法 | |
CN1733251A (zh) | 治疗糖尿病及其并发症的芪蛭降糖制剂及其制备方法 | |
CN1278674C (zh) | 一种清咽口腔崩解片及其制备方法 | |
CN1593635A (zh) | 一种藿香正气口腔崩解片及其制备方法 | |
CN1301108C (zh) | 美他多辛分散片及其制备方法 | |
CN1593621A (zh) | 一种生脉口腔崩解片及其制备方法 | |
CN1843442A (zh) | 藿香正气口腔崩解片及制备方法和质量控制方法 | |
CN1593626A (zh) | 一种心痛宁口腔崩解片及其制备方法 | |
CN1586555A (zh) | 一种桂枝茯苓口腔崩解片及其制备方法 | |
CN1593627A (zh) | 一种百宝丹口腔崩解片及其制备方法 | |
CN1293895C (zh) | 一种喉症口腔崩解片及其制备方法 | |
CN1850268A (zh) | 治疗感冒的云实中药制剂及制备方法和质量控制方法 | |
CN1593636A (zh) | 一种柴胡口腔崩解片及其制备方法 | |
CN1259037C (zh) | 一种抗病毒口腔崩解片及其制备方法 | |
CN1569160A (zh) | 治疗心脑血管疾病的中药药物制剂及其制备方法 | |
CN1586593A (zh) | 一种野菊花口腔崩解片及其制备方法 | |
CN1891265A (zh) | 一种参附口腔崩解片及其制备方法 | |
CN1586532A (zh) | 一种六神口腔崩解片及其制备方法 | |
CN1593628A (zh) | 一种三臣口腔崩解片及其制备方法 | |
CN1813937A (zh) | 一种治疗高脂血症的复方制剂及其制备方法 | |
CN1593623A (zh) | 一种通心络口腔崩解片及其制备方法 | |
CN1593622A (zh) | 一种双黄连口腔崩解片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGDONG TIANZHIJIAO LIFE SCIENCE CO., LTD. Free format text: FORMER OWNER: ZHANG QINGLONG Owner name: TIANJIN TASLY PHARMACEUTICAL CO., LTD. Effective date: 20050422 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050422 Address after: 510610 Guangzhou Tianhe District City Lin Road No. 150, Tianyu Garden Plaza Accord Room 802 Applicant after: Guangzhou Tianzhijiao Life Technology Co., Ltd. Co-applicant after: Tianjin Tianshili Pharmaceutical Co., Ltd. Address before: 100036, 1, building 1, 1801, Lianhua District, Beijing, Haidian District Applicant before: Zhang Qinglong |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |